REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $541,431 | -18.6% | 28,632 | -2.4% | 0.01% | -16.7% |
| Q4 2022 | $665,545 | +6.5% | 29,345 | +24.2% | 0.01% | 0.0% |
| Q3 2022 | $625,000 | -1.1% | 23,632 | -7.6% | 0.01% | 0.0% |
| Q2 2022 | $632,000 | -56.9% | 25,588 | -42.0% | 0.01% | -62.5% |
| Q1 2022 | $1,465,000 | -9.5% | 44,138 | -10.8% | 0.02% | -11.1% |
| Q4 2021 | $1,618,000 | -26.1% | 49,491 | -5.2% | 0.02% | -14.3% |
| Q3 2021 | $2,189,000 | +0.6% | 52,212 | -6.7% | 0.02% | +10.5% |
| Q2 2021 | $2,175,000 | -17.1% | 55,984 | -27.2% | 0.02% | -26.9% |
| Q1 2021 | $2,623,000 | -14.3% | 76,888 | +13.9% | 0.03% | -23.5% |
| Q4 2020 | $3,061,000 | +795.0% | 67,481 | +913.7% | 0.03% | +1033.3% |
| Q2 2019 | $342,000 | -14.9% | 6,657 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $402,000 | +49.4% | 7,009 | +9.4% | 0.00% | +50.0% |
| Q4 2018 | $269,000 | -46.6% | 6,404 | -4.0% | 0.00% | -33.3% |
| Q3 2018 | $504,000 | – | 6,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |